Kate O'Connell (Dublin Bay South, Fine Gael) | Oireachtas source

There is great data from the PCRS. If one gives somebody something, it is difficult to take it off them. My question is, if new data emerges that shows that the efficacy is less than what it was at the start, is there any process to pull back on a drug that may have been approved for whatever other reasons it was approved? Once the horse is out, it is gone.